0
Transplantation |

Utility and Safety of Transbronchial Biopsies Among Lung Transplant Recipients Admitted to the MICU

Manish Mohanka*, MD; Amit Banga, MD; Thomas Gildea, MD
Author and Funding Information

Cleveland Clinic Foundation, Cleveland, OH


Chest. 2012;142(4_MeetingAbstracts):1102A. doi:10.1378/chest.1390377
Text Size: A A A
Published online

Abstract

SESSION TYPE: Lung Transplantation Posters

PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM

PURPOSE: To study the utility and safety of bronchoscopy/transbronchial biopsies (TBBX) among lung transplant (LTx) recipients in MICU

METHODS: We reviewed charts and studied indications, histopathology and safety of bronchoscopy/TBBX for LTx recipients in MICU between 1/1/2009 and 12/31/2011. Study was IRB approved.

RESULTS: Eighteen patients underwent twenty bronchoscopy/TBBXs. Mean age (+/-SD) at transplant was 54.4+/-13.5 years. Bronchoscopy was performed 195+/-190 days post-transplant and 2.9+/-3.1 days after MICU admission. UIP/IPF and COPD were common transplant diagnoses. Ten patients received bilateral lung transplants. Hypoxemia was the most common reason for MICU admission. Transplant lung infiltrates were observed among all patients on imaging (CT/CXR). TBBX was mostly performed to differentiate between infection/acute cellular rejection (ACR). Mechanical ventilation was required during eighteen procedures. Diagnostic tissue to evaluate for ACR was not obtained during 5/18 procedures. Fifty-one diagnostic specimens were obtained after ninety-one passes. Fluoroscopy was used for 8 procedures. The most common histopathology was acute lung injury (ALI)/inflammation (n=14). Of the four ACRs, three were minimal (A1) and one was mild (A2). ALI was seen on three ACRs. All ACRs were observed within one year post-transplant. A2 rejection was treated with pulsed steroids, and A1 with augmented immunosuppression. C3D/C4D was negative for 12 and tissue non-diagnostic for 2 procedures. Concomitant TBBX and BAL were done among sixteen patients. ALI was seen among seven of eight patients who required directed antimicrobials for pathogenic microorganisms. These included bacteria (P.aeruginosa,MRSA), viruses (CMV,RSV) and fungi (A.fumigatus). Two patients had coexisting ACR. Complications resulting in aborted procedure included hypoxia (1), hypotension (1) and atrial fibrillation with rapid ventricular rate (2 in same patient). One patient (5%) had pneumothorax despite fluoroscopy guidance, requiring chest tube.

CONCLUSIONS: TBBX diagnosed minimal/mild ACR (A1,A2), all within first year post-transplant ALI frequently associated with acute infection, found on BAL Complication rate high

CLINICAL IMPLICATIONS: TBBX may help diagnose ACR within the first post-LTx year on mechanical ventilation in MICU. Mild/minimal ACR unlikely to explain acute respiratory failure Infections (on BAL) may commonly cause respiratory failure. Complication rate is high- experienced bronchoscopy centers should perform

DISCLOSURE: The following authors have nothing to disclose: Manish Mohanka, Amit Banga, Thomas Gildea

No Product/Research Disclosure Information

Cleveland Clinic Foundation, Cleveland, OH

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543